Investigating the assumption of homogeneity of treatment effects in clinical studies with application to meta-analysis

Pharmaceutical Statistics

Volumn 11, Issue 1, 2012, Pages 49-56

  Julious, Steven A ^a   Whitehead, Anne ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

bootstrapping; clinical trials; meta analysis; normal probability plots; simulated envelopes

Indexed keywords

PAROXETINE; PLACEBO;

ARTICLE; BOOTSTRAPPING; CLINICAL TRIAL (TOPIC); HUMAN; META ANALYSIS; MULTICENTER STUDY (TOPIC); PROBABILITY; THERAPY EFFECT;

CLINICAL TRIALS AS TOPIC; HUMANS; META-ANALYSIS AS TOPIC; MODELS, STATISTICAL; PROBABILITY; RESEARCH SUBJECTS; TREATMENT OUTCOME;

EID: 84856535666     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.494     Document Type: Article

References (16)

1. Committe for Propriety Medicinal Products. Points to consider on application with 1. Meta analysis; 2. One pivotal study. CPMP/EWP/2330/99, European Medicines Agency, London, 2001. Available at: (accessed 06.02.2011).
2. Webber DW, Montague TM, Bird NP,. Meta-analysis of QTc interval-pooling data from heterogeneous trials. Pharmaceutical Statistics 2002; 1 (1): 17-23.
3. Whitehead A,. Meta-analysis of Controlled Clinical Trials. Wiley: Chichester, 2002.
4. Hardy RF, Thompson SG,. Detecting and describing heterogeneity in meta analysis. Statistics in Medicine 1998; 17: 841-856. (Pubitemid 28185164)
5. Higgins JPT, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002; 21: 1539-1558. (Pubitemid 34746062)
6. Mood AM, Graybill FA, Boes DC,. Introduction to the Theory of Statistics (3rd edn). Kogakusha Tokyo: McGraw-Hill, 1974.
7. Conover WJ,. Practical Nonparametric Statistics (3rd edn). Wiley: New York, 1999.
8. Friendly M,. SAS System for Statistical Graphics (1st edn). SAS Press: Cary, NC, USA, 1991.
9. Blom G,. Statistical Estimates and Transformed Beta Variables. Wiley: New York, 1958.
10. Tukey JW,. The future of data analysis. Annals of Mathematical Statistics 1962; 33: 22.
11. Julious SA, Wang SJ,. Issues with indirect comparisons in clinical trials particularly with respect to non-inferiority trials. Drug Information Journal 2008; 42 (6): 635-633.
12. Higgins JPT, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analysis. British Medical Journal 2003; 327: 557-560.
13. Galbraith RF,. A note on graphical presentation of estimated odds ratios from several trials. Statistics in Medicine 1988; 7: 889-894.
14. Cook RD, Weisberg S,. Residuals and Influence in Regression. Chapman and Hall: London, 1982.
15. Lee KJ, Thompson SG,. Flexible parametric models for random effects distributions. Statistics in Medicine 2008; 27: 418-434. (Pubitemid 351227877)
16. Baker R, Jackson D,. A new approach to outliers in meta-analysis. Health Care in Management Science 2008; 11: 121-131.